FrancophonIA/ELRC3.0 huggingface dataset:
English: Breastfeeding
Icelandic: Kyrningahrap
English: The efficacy supported by the extrapolation principle stated above was confirmed by a double-blind, randomised, placebo-controlled study.
Icelandic: Verkunin, sem studd var ofangreindri framreikningsreglu, var staðfest í tvíblindri, slembiraðaðri, samanburðarrannsókn með lyfleysu.
English: NAME OF THE MARKETING AUTHORISATION HOLDER UCB Pharma S.A.
Icelandic: Markaðsleyfishafi UCB Pharma
English: This will be until you reach a maintenance dose of between 100 mg and 200 mg twice a day.
Icelandic: Þetta er gert þar til þú nærð viðhaldsskammti milli 100 mg og 200 mg tvisvar sinnum á sólarhring.
English: Lacosamide is primarily eliminated from the systemic circulation by renal excretion and biotransformation.
Icelandic: Brotthvarf lacosamíðs úr blóðrásinni er aðallega með útskilnaði í gegnum nýru og niðurbroti.
English: NAME OF THE MEDICINAL PRODUCT Lacosamide UCB 200 mg film-coated tablets <For 56 x 1 and 14 x 1 film-coated tablet> Lacosamide UCB 200 mg tablets lacosamide
Icelandic: Lacosamide UCB 200 mg filmuhúðaðar töflur Fyrir 56 x 1 og 14 x 1 filmuhúðaðar töflur Lacosamide UCB 200 mg töflur lacosamíð
English: Population pharmacokinetic analyses in different age groups estimated that concomitant treatment with other antiepileptic medicinal products known to be enzyme inducers (carbamazepine, phenytoin, phenobarbital, in various doses) decreased the overall systemic exposure of lacosamide by 25 % in adults and 17 % in paediatric patients.
Icelandic: Samkvæmt mati á þýðisgreiningu á lyfjahvörfum mismunandi aldurshópa kom fram að heildarútsetning fyrir lacosamíði minnkar um 25 % í fullorðnum og 17 % hjá börnum samhliða meðferð með öðrum flogaveikilyfjum sem eru þekktir ensímhvatar (carbamazepín, fenýtóin, fenóbarbital í mismunandi skömmtum).
English: Very common: may affect more than 1 in 10 people Headache;
Icelandic: Geta komið fyrir hjá fleiri en 1 af 10 einstaklingum
English: • Fever (pyrexia);
Icelandic: • sundli;
English: Lacosamide UCB 50 mg film-coated tablets
Icelandic: Lacosamide UCB 50 mg filmuhúðaðar töflur
English: EU/1/19/1383/004 EU/1/19/1383/005 EU/1/19/1383/006 EU/1/19/1383/007 EU/1/19/1383/008 EU/1/19/1383/009
Icelandic: EU/1/19/1383/001 EU/1/19/1383/002
English: Lacosamide UCB 150 mg film-coated tablets
Icelandic: Lacosamide UCB 150 mg filmuhúðaðar töflur
English: Carton 14 tablets - week 4
Icelandic: 14 filmuhúðaðar töflur Vika 4
English: Decreased feeling or sensitivity, difficulty in articulating words, disturbance in attention; Noise in the ear such as buzzing, ringing or whistling;
Icelandic: Minnkuð skynjun eða næmi, talörðugleikar, einbeitingarskortur;
English: How to store Lacosamide UCB
Icelandic: Hvernig geyma á Lacosamide UCB
English: Lacosamide UCB 50 mg film-coated tablets Lacosamide UCB 100 mg film-coated tablets Lacosamide UCB 150 mg film-coated tablets Lacosamide UCB 200 mg film-coated tablets
Icelandic: Lacosamide UCB 50 mg filmuhúðaðar töflur Lacosamide UCB 100 mg filmuhúðaðar töflur Lacosamide UCB 150 mg filmuhúðaðar töflur Lacosamide UCB 200 mg filmuhúðaðar töflur
English: Taking Lacosamide UCB
Icelandic: Taka Lacosamide UCB
English: Lacosamide UCB 50 mg film-coated tablets Lacosamide UCB 100 mg film-coated tablets Lacosamide UCB 150 mg film-coated tablets Lacosamide UCB 200 mg film-coated tablets lacosamide
Icelandic: Lacosamide UCB 50 mg filmuhúðaðar töflur Lacosamide UCB 100 mg filmuhúðaðar töflur Lacosamide UCB 150 mg filmuhúðaðar töflur Lacosamide UCB 200 mg filmuhúðaðar töflur lacosamíð
English: What Lacosamide UCB looks like and contents of the pack
Icelandic: Lýsing á útliti Lacosamide UCB og pakkningastærðir
English: NAME OF THE MEDICINAL PRODUCT Lacosamide UCB 10 mg/ml syrup
Icelandic: Lacosamide UCB 10 mg/ml saft
English: If you have missed a dose within the first 6 hours of the scheduled dose, take it as soon as you remember.
Icelandic: Ef gleymist að taka skammt skal taka gleymda skammtinn eins fljótt og munað er eftir honum ef minna en 6 klukkustundir eru síðan taka átti skammtinn.
English: A small number of people being treated with antiepileptic medicinal products such as lacosamide have had thoughts of harming or killing themselves.
Icelandic: Vart hefur orðið við sjálfsskaðahugsanir eða sjálfsvígshugsanir hjá fáeinum einstaklingum sem hafa fengið meðferð með flogaveikilyfjum eins og lacosamíði.
English: TOTAL daily dose
Icelandic: DAGSETNING ENDURSKOÐUNAR TEXTANS
English: Lacosamide UCB 100 mg film-coated tablets
Icelandic: Lacosamide UCB 100 mg filmuhúðaðar töflur
English: Dyspepsia
Icelandic: Töflukjarni
English: EU/1/19/1383/004 14 film-coated tablets EU/1/19/1383/005 14 x 1 film-coated tablet EU/1/19/1383/006 28 film-coated tablets EU/1/19/1383/007 56 film-coated tablets EU/1/19/1383/008 56 x 1 film-coated tablet EU/1/19/1383/009 168 film-coated tablets
Icelandic: EU/1/19/1383/004 14 filmuhúðaðar töflur EU/1/19/1383/005 14 x 1 filmuhúðuð tafla EU/1/19/1383/006 28 filmuhúðaðar töflur EU/1/19/1383/007 56 filmuhúðaðar töflur EU/1/19/1383/008 56 x 1 filmuhúðuð tafla EU/1/19/1383/009 168 filmuhúðaðar töflur
English: EU/1/19/1383/022 14 film-coated tablets EU/1/19/1383/023 14 x 1 film-coated tablet EU/1/19/1383/024 28 film-coated tablets EU/1/19/1383/025 56 film-coated tablets EU/1/19/1383/026 56 x 1 film-coated tablet
Icelandic: EU/1/19/1383/022 14 filmuhúðaðar töflur EU/1/19/1383/023 14 x 1 filmuhúðuð tafla EU/1/19/1383/024 28 filmuhúðaðar töflur EU/1/19/1383/025 56 filmuhúðaðar töflur EU/1/19/1383/026 56 x 1 filmuhúðuð tafla
English: In paediatric patients weighing 50 kg or more and in adult patients with severe renal impairment (CLCR ≤ 30 ml/min) or with end-stage renal disease, a maximum dose of 250 mg/day is recommended and the dose titration should be performed with caution.
Icelandic: Fyrir sjúklinga á barnsaldri sem vega 50 kg eða meira og fullorðna sjúklinga með vægt til í meðallagi mikið skerta lifrarstarfsemi er ráðlagður hámarksskammtur 300 mg/sólarhring.
English: PHARMACEUTICAL FORM AND CONTENTS Multipack: 168 (3 packs of 56) film-coated tablets.
Icelandic: 168 (3 pakkningar með 56) filmuhúðaðar töflur.
English: Instructions for use are provided in the package leaflet.
Icelandic: Leiðbeiningar um notkun má finna á fylgiseðli í öskju.
English: In accordance with current clinical practice, if lacosamide has to be discontinued, it is recommended this be done gradually (e.g. taper the daily dose by 200 mg/week).
Icelandic: Ef hætta þarf meðferð er ráðlagt að gera það smátt og smátt (t.d. minnka sólarhringsskammt um 200 mg/viku) til samræmis við núverandi klíníska meðferðarhætti.
English: Lacosamide is effectively removed from plasma by haemodialysis.
Icelandic: Lacosamíð er fjarlægt á áhrifaríkan hátt með blóðskilun.
English: EU/1/19/1383/010 14 film-coated tablets EU/1/19/1383/011 14 x 1 film-coated tablet EU/1/19/1383/012 28 film-coated tablets EU/1/19/1383/013 56 film-coated tablets EU/1/19/1383/014 56 x 1 film-coated tablet EU/1/19/1383/015 168 film-coated tablets
Icelandic: EU/1/19/1383/010 14 filmuhúðaðar töflur EU/1/19/1383/011 14 x 1 filmuhúðuð tafla EU/1/19/1383/012 28 filmuhúðaðar töflur EU/1/19/1383/013 56 filmuhúðaðr töflur EU/1/19/1383/014 56 x 1 filmuhúðuð tafla EU/1/19/1383/015 168 filmuhúðaðar töflur
English: NAME OF THE MEDICINAL PRODUCT Lacosamide UCB 50 mg film-coated tablets <For 56 x 1 and 14 x 1 film-coated tablet> Lacosamide UCB 50 mg tablets lacosamide
Icelandic: Lacosamide UCB 50 mg filmuhúðaðar töflur Fyrir 56 x 1 og 14 x 1 filmuhúðaðaðar töflur Lacosamide UCB 50 mg töflur lacosamíð
English: Tablet core microcrystalline cellulose hydroxypropylcellulose hydroxypropylcellulose (low substituted) silica, colloidal, anhydrous crospovidone (polyplasdone XL-10 Pharmaceutical Grade) magnesium stearate
Icelandic: Krosspóvídón (pólýplastón XL-10 Pharmaceutical Grade) Magnesíum sterat
English: This will be until you reach a maintenance dose of between 100 mg and 300 mg twice a day.
Icelandic: Þetta er gert þar til þú nærð viðhaldsskammti milli 100 mg og 300 mg tvisvar sinnum á sólarhring.
English: One tablet of Lacosamide UCB 100 mg contains 100 mg lacosamide.
Icelandic: Hver Lacosamide UCB tafla inniheldur 100 mg lacosamíð.
English: Your doctor may increase your twice daily dose every week by 1 mg (0.1 ml), for each kg of body weight.
Icelandic: Læknirinn getur aukið skammtinn sem þú tekur tvisvar sinnum á sólarhring um 1 mg (0,1 ml) fyrir hvert kg líkamsþyngdar í hverri viku.
English: (2) See Description of selected adverse reactions.
Icelandic: Sjá lýsingu á völdum aukaverkunum.
English: NAME OF THE MEDICINAL PRODUCT Lacosamide UCB 100 mg film-coated tablets <For 56 x 1 and 14 x 1 film-coated tablet> Lacosamide UCB 100 mg tablets lacosamide
Icelandic: Lacosamide UCB 100 mg filmuhúðaðar töflur Fyrir 56 x 1 og 14 x 1 filmuhúðaðar töflur Lacosamide UCB 100 mg töflur lacosamíð
English: Lacosamide UCB syrup contains sodium.
Icelandic: Saltinnihald Lacosamide UCB saft inniheldur natríum.
English: Lacosamide UCB 200 mg <Justification for not including Braille accepted> 56 x 1 and 14 x 1 film-coated tablet
Icelandic: Lacosamide UCB 200 mg <Fallist hefur verið á rök fyrir undanþágu frá kröfu um blindraletur> 56 x 1 og 14 x 1 filmuhúðuð tafla
English: Diluents: sodium chloride 9 mg/ml (0.9 %) solution for injection glucose 50 mg/ml (5 %) solution for injection lactated Ringer's solution for injection.
Icelandic: Natríumklóríð 9 mg/ml (0,9%) stungulyf, lausn
English: Following a 4-hour haemodialysis treatment, AUC of lacosamide is reduced by approximately 50 %.
Icelandic: Eftir 4 klst. blóðskilunarmeðferð hefur flatarmál lacosamíð undir þéttniferli minnkað um u.þ.b. 50 %.
English: Lacosamide UCB 150 mg <Justification for not including Braille accepted> 56 x 1 and 14 x 1 film-coated tablet
Icelandic: Lacosamide UCB 150 mg <Fallist hefur verið á rök fyrir undanþágu frá kröfu um blindraletur> 56 x 1 og 14 x 1 filmuhúðuð tafla
English: To be used twice daily for children from 4 years of age weighing less than 20 kg Weight
Icelandic: Skal nota tvisvar sinnum á sólarhring hjá börnum frá 4 ára aldri sem eru léttari en 20 kg Þyngd Upphafsskammtur:
English: Stevens-Johnson syndrome(1) Toxic epidermal necrolysis(1)
Icelandic: StevensJohnson heilkenni Eitrunardreplos húðþekju
English: Fertility
Icelandic: Karmellósnatríum
English: EU/1/19/1383/016 14 film-coated tablets EU/1/19/1383/017 14 x 1 film-coated tablet EU/1/19/1383/018 28 film-coated tablets EU/1/19/1383/019 56 film-coated tablets EU/1/19/1383/020 56 x 1 film-coated tablet
Icelandic: EU/1/19/1383/016 14 filmuhúðaðar töflur EU/1/19/1383/017 14 x 1 filmuhúðuð tafla EU/1/19/1383/018 28 filmuhúðaðar töflur EU/1/19/1383/019 56 filmuhúðaðar töflur EU/1/19/1383/020 56 x 1 filmuhúðuð tafla
English: Lacosamide UCB 50 mg <Justification for not including Braille accepted> 56 x 1 and 14 x 1 film-coated tablet
Icelandic: Lacosamide UCB 50 mg <Fallist hefur verið á rök fyrir undanþágu frá kröfu um blindraletur> 56 x 1 og 14 x 1 filmuhúðuð tafla
English: Conversion to monotherapy
Icelandic: Skipt í einlyfjameðferð
English: Carmellose sodium Sorbitol liquid (crystallizing) (E420) Polyethylene glycol 4000
Icelandic: Sorbitól lausn (kristölluð) (E420)
English: Lacosamide UCB 100 mg <Justification for not including Braille accepted> 56 x 1 and 14 x 1 film-coated tablet
Icelandic: Lacosamide UCB 100 mg <Fallist hefur verið á rök fyrir undanþágu frá kröfu um blindraletur> 56 x 1 og 14 x 1 filmuhúðuð tafla
English: Hepatic impairment
Icelandic: Sæluvíma Geðrof
English: To be taken twice daily for children from 4 years of age weighing less than 40 kg Weight Starting dose: 0.1 ml/kg
Icelandic: Einlyfjameðferðarskammtar sem taka skal tvisvar sinnum á sólarhring fyrir börn frá 4 ára aldri og eru léttari en 40 kg Þyngd 0,1 ml/kg (1 mg/kg) Byrjunarskammtur
English: What is in this leaflet
Icelandic: Merkingar á þynnum
English: Your doctor may then increase your twice daily dose every week by 1 mg (0.1 ml) for each kg of body weight.
Icelandic: Læknirinn getur aukið skammtinn sem þú tekur tvisvar sinnum á sólarhring um 1 mg (0,1 ml) á hvert kg líkamsþyngdar í hverri viku.
English: PHARMACEUTICAL FORM AND CONTENTS 200 mg/20 ml
Icelandic: 200 mg/20 ml
English: Based on data in adults, in paediatric patients weighing less than 50 kg with mild to moderate hepatic impairment a reduction of 25% of the maximum dose should be applied.
Icelandic: Byggt á upplýsingum um fullorðna, ætti að minnka hámarksskammt um 25 % hjá börnum sem vega minna en 50 kg með vægt eða miðlungsskerta lifrarstarfsemi.
English: Based on data in adults, in paediatric patients weighing less than 50 kg with mild to moderate hepatic impairment a reduction of 25 % of the maximum dose should be applied.
Icelandic: Byggt á upplýsingum um fullorðna, ætti að minnka hámarksskammt um 25% hjá börnum sem vega minna en 50 kg með vægt eða miðlungsskerta lifrarstarfsemi.
English: Lacosamide UCB 10 mg/ml solution for infusion lacosamide
Icelandic: Lacosamide UCB 10 mg/ml innrennslislyf, lausn lacosamíð
English: When you take Lacosamide UCB on its own
Icelandic: Þegar Lacosamide UCB er notað eitt og sér
English: Talk to your doctor before using Lacosamide UCB if: you have thoughts of harming or killing yourself.
Icelandic: Leitið ráða hjá lækninum áður en Lacosamide UCB er notað ef:
English: To be taken twice daily for children from 4 years of age weighing less than 20 kg Weight
Icelandic: Skal taka tvisvar sinnum á sólarhring hjá börnum frá 4 ára aldri sem eru léttari en 20 kg Þyngd Upphafsskammtur:
English: To be taken twice daily for children and adolescents from 4 years of age weighing 20 kg to under 30 kg: Weight Starting dose: 0.1 ml/kg
Icelandic: Skammtar viðbótarmeðferðar sem taka á tvisvar sinnum á sólarhring hjá börnum og unglingum frá 4ra ára aldri sem eru 20 kg til allt að 30 kg að þyngd Þyngd 0,1 ml/kg (1 mg/kg) Byrjunarskammtur
English: To be taken twice daily for children and adolescents from 4 years of age weighing 30 kg to under 50 kg: Weight Starting dose: 0.1 ml/kg
Icelandic: Skammtar viðbótarmeðferðar sem taka á tvisvar sinnum á sólarhring hjá börnum og unglingum frá 4ra ára aldri sem eru 30 kg til allt að 50 kg að þyngd Þyngd 0,1 ml/kg (1 mg/kg) Byrjunarskammtur
English: Gait disturbance Asthenia
Icelandic: Ráðlagður hámarksskammtur hjá sjúklingum
English: Use of a loading dose is not recommended in adolescents and children weighing less than 50 kg. Children less than 4 years
Icelandic: Gjöf hleðsluskammts er ekki ráðlögð hjá börnum og unglingum léttari en 50 kg.
English: Angioedema(1) Urticaria(1)
Icelandic: Títantvíoxíð (E171)
English: Taking Lacosamide UCB with other antiepileptic medicines - Children and adolescents with a body weight of 20 kg to under 30 kg - This is for information only.
Icelandic: - Börn og unglingar sem vega frá 20 kg til allt að 30 kg - þetta er aðeins til upplýsinga.
English: To be used twice daily for children and adolescents from 4 years of age weighing 20 kg to under 30 kg: Weight Starting dose: 0.1 ml/kg
Icelandic: Skammtar viðbótarmeðferðar sem taka á tvisvar sinnum á sólarhring hjá börnum og unglingum frá 4 ára aldri sem eru 20 kg til allt að 30 kg að þyngd Þyngd 0,1 ml/kg (1 mg/kg) Byrjunarskammtur
English: What Lacosamide UCB contains
Icelandic: Lacosamide UCB inniheldur
English: Risk related to lacosamide There are no adequate data from the use of lacosamide in pregnant women.
Icelandic: Takmörkuð gögn eru fyrirliggjandi um notkun lacosamíð á meðgöngu.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each ml of solution for infusion contains 10 mg lacosamide.
Icelandic: Hver ml af innrennslislyf, lausn inniheldur 10 mg lacosamíð.
English: Loading dose
Icelandic: Önnur lyf
English: Taking Lacosamide UCB with other antiepileptic medicines - Children and adolescents with a body weight of 30 kg to under 50 kg - This is for information only.
Icelandic: - Börn og unglingar sem vega frá 30 kg til allt að 50 kg - þetta er aðeins til upplýsinga.
English: The efficacy of lacosamide as adjunctive therapy at recommended doses (200 mg/day, 400 mg/day) was established in 3 multicenter, randomised, placebo-controlled clinical trials with a 12-week maintenance period.
Icelandic: Í þremur fjölsetra, slemiröðuðum, klínískum samanburðarrannsóknum með lyfleysu með 12 vikna viðhaldstímabili var verkun lacosamíðs sem viðbótarmeðferð í ráðlögðum skömmtum (200 mg/sólarhring og 400 mg/sólarhring) staðfest.
English: Liver function test abnormal(2)
Icelandic: Óeðlilegar niðurstöður lifrarprófa Hækkuð lifrarensím (> 2x ULN)
English: NAME OF THE MEDICINAL PRODUCT Lacosamide UCB 150 mg film-coated tablets lacosamide
Icelandic: Lacosamide UCB 150 mg filmuhúðaðar töflur lacosamíð
English: Excipients which may cause intolerance
Icelandic: Hjálparefni sem valdið geta óþoli
English: Dose-related prolongations in PR interval with lacosamide have been observed in clinical studies.
Icelandic: Í klínískum rannsóknum á lacosamíði hefur verið greint frá skammtaháðri lengingu PR bils.
English: NAME OF THE MEDICINAL PRODUCT Lacosamide UCB 200 mg film-coated tablets lacosamide
Icelandic: Lacosamide UCB 200 mg filmuhúðaðar töflur lacosamíð
English: The elimination half-life of lacosamide is approximately 13 hours.
Icelandic: Helmingunartími brotthvarfs lacosamíðs er u.þ.b. 13 klst.
English: {Name and Address} <{tel}> <{fax}> <{e-mail}>
Icelandic: {Nafn og heimilsfang} <{sími}> <{fax}> <{netfang}>
English: How quickly will the treatment start to work?
Icelandic: Hve fljótt byrjar lyfið að verka?
English: If you forget to take a dose, take it as soon as you remember.
Icelandic: Ef þú gleymir að taka skammt, skaltu taka hann um leið og þú manst eftir því.
English: 14 days
Icelandic: 14 dagar
English: Maintenance dose: 6 months.
Icelandic: Viðhaldsskammtur: 6 mánuðir.
English: 7 to 21 days.
Icelandic: 7 til 21 dagur.
English: Breakpoints (according to EUCAST)
Icelandic: Viðmið (samkvæmt EUCAST)
English: Keep the bottle tightly closed.
Icelandic: Geymið flöskuna vel lokaða.
English: Up to 28 days.
Icelandic: Allt að 28 dagar.
English: It is best to take medicine at the same time each day.
Icelandic: Best er að taka lyfið á sama tíma á hverjum degi.
English: Children to 11 years old
Icelandic: Börn að 11 ára aldri
English: Remove the syringe from the bottle;
Icelandic: Fjarlægið sprautuna úr flöskunni;
English: Taking Diflucan with food and drink
Icelandic: Ef Diflucan er tekið með mat eða drykk
English: Ten of these patients were concomitantly receiving diuretics.
Icelandic: Tíu þessara sjúklinga fengu samtímis þvagræsilyf.
English: Your condition should start to clear up within a few days but it may take up to a week.
Icelandic: Sýkingin ætti að byrja að ganga til baka innan nokkurra daga en það getur tekið allt að eina viku.
English: Open the bottle (safety cap);
Icelandic: Opnið flöskuna (öryggislok);
English: Glycerol 85%
Icelandic: Glýseról 85%
English: The dose will be based on the child's weight in kilograms.
Icelandic: Skammturinn miðast við þyngd barnsins í kílóum.
English: Usually at least 6 to 8 weeks.
Icelandic: Yfirleitt a.m.k. 6 til 8 vikur.
English: 1 bottle - 150 ml
Icelandic: 1 flaska - 150 ml
English: Cytochrome P450
Icelandic: Cýtókróm P450
English: Diflucan may affect your liver.
Icelandic: Diflucan getur haft áhrif á lifur.
English: Always take your medicine exactly as your doctor has told you.
Icelandic: Takið lyfið alltaf eins og læknirinn hefur sagt til um.
English: Each pack contains 1 hard capsule.
Icelandic: Hver pakkning inniheldur 1 hart hylki.
English: 100% after each dialysis
Icelandic: 100% eftir hverja himnuskilun.
English: Diflucan can be taken with or without food.
Icelandic: Hægt er að taka Diflucan með eða án matar.
English: Check with your doctor or nurse if you are not sure why you are being given Diflucan.
Icelandic: Ræddu vð lækninn eða hjúkrunarfræðing ef þú ert ekki viss um hvers vegna þér er gefið Diflucan.
English: The following information is intended for medical or healthcare professionals only:
Icelandic: Eftirfarandi upplýsingar eru einungis ætlaðar læknum og heilbrigðisstarfsfólki
English: No studies have been performed on the effects of Diflucan on the ability to drive or use machines.
Icelandic: Engar rannsóknir hafa verið gerðar á áhrifum Diflucan á hæfni til aksturs eða notkunar véla.
English: - May be harmful to teeth if used for periods of longer than 2 weeks.
Icelandic: - Lyfið getur skaðað tennur ef það er notað lengur en í 2 vikur.
English: Your condition should start to clear up within a few days - some women notice an improvement in one day.
Icelandic: Sýkingin ætti að byrja að ganga til baka innan nokkurra daga - sumar konur finna mun á fyrsta degi.
English: Measure 66 ml of still water and add the water to the bottle.
Icelandic: Mælið 66 ml af vatni og bætið því í flöskuna.
English: Susceptibility in vitro
Icelandic: Næmi in vitro
English: The usual adult dose should be given.
Icelandic: Gefa á venjulegan fullorðinsskammt.
English: 5-nortriptyline and/or S-amitriptyline may be measured at initiation of the combination therapy and after one week.
Icelandic: 5-nortriptylín og/eða S-amitriptylín í sermi má hugsanlega mæla við upphaf samsettrar meðferðar og eftir eina viku.
English: Add water up to the level marked on the bottle (this corresponds to adding 24 ml of water)
Icelandic: Bætið vatni í flöskuna upp að merkinu (jafngildir því að bæta við 24 ml af vatni)
English: Common side effects which affect 1 to 10 users in 100 are listed below:
Icelandic: Algengar aukaverkanir, sem koma fyrir hjá 1 til 10 af hverjum 100 notendum eru taldar hér að neðan:
English: Add a small quantity of still water and shake it vigorously.
Icelandic: Bætið litlum skammti af vatni við og hristið kröftuglega.
English: This leaflet was last approved in
Icelandic: Fylgiseðillinn var síðast samþykktur í
English: 1 to 3 weeks
Icelandic: 1 til 3 vikur.
English: Swallow the capsule whole with a glass of water.
Icelandic: Gleypa á hylkið heilt með glasi af vatni.
English: Children and adolescents (0 to 17 years old)
Icelandic: Börn og unglingar (0 til 17 ára)
English: Pharmacokinetic data were assessed for 113 paediatric patients from 5 studies; 2 single-dose studies, 2 multiple-dose studies, and a study in premature neonates.
Icelandic: Lagt var mat á lyfjahvarfaniðurstöður hjá 113 börnum í fimm rannsóknum; 2 stakskammta rannsóknum, 2 fjölskammta rannsóknum og 1 rannsókn hjá fyrirburum.
English: The symptoms of a possible overdose may include hearing, seeing, feeling and thinking things that are not real (hallucination and paranoid behaviour).
Icelandic: Einkenni hugsanlegrar ofskömmtunar geta verið að sjá, heyra eða skynja eitthvað sem ekki er raunverulegt og ranghugmyndir (ofskynjanir og ofsóknarkennd hegðun).
English: Somnolence, insomnia
Icelandic: Svefnhöfgi, svefnleysi.
English: Make sure your doctor knows if you are taking any of the following medicines:
Icelandic: Gakktu úr skugga um að læknir þinn viti af því ef þú notar einhver eftirtalinna lyfja:
English: However, growth rates may vary widely in individuals, and by age.
Icelandic: Vaxtarhraði getur þó verið breytilegur milli einstaklinga og eftir aldri.
English: Close the bottle with the safety cap; the adapter will remain on the bottle neck.
Icelandic: Lokið flöskunni með öryggislokinu, millistykkið verður eftir í stút flöskunnar.
English: Like all medicines, Diflucan can cause side effects, although not everybody gets them
Icelandic: Eins og við á um öll lyf getur Diflucan valdið aukaverkunum en það gerist þó ekki hjá öllum.
English: The clinical significance of results obtained in these studies is unknown.
Icelandic: Klínískt mikilvægi þessara niðurstaðna er ekki þekkt.
English: You can take your medicine with or without a meal.
Icelandic: Lyfið er hægt að taka með eða án matar.
English: However tell your doctor or pharmacist if you think that a dose has been forgotten.
Icelandic: Láttu lækninn eða lyfjafræðing samt vita ef þú telur að skammtur hafi gleymst.
English: Of a radioactive dose, only 11% is excreted in a changed form in the urine.
Icelandic: Aðeins 11% af geislavirkum skammti eru skilin út í þvagi í breyttu formi.
English: As you will be given this medicine under close medical supervision, it is unlikely that a dose would be missed.
Icelandic: Þar sem þér verður gefið lyfið undir nánu eftirliti heilbrigðisstarfsfólks er ólíklegt að skammtur gleymist.